Jeremiah Brown, PhD, a professor of epidemiology, of The Dartmouth Institute for Health Policy and Clinical Practice and of biomedical data science at Dartmouth’s Geisel School of Medicine, has been named Chair of the Science of Implementation in Health and Healthcare Study Section (SIHH), a standing study section in the Center for Scientific Review at the National Institutes of Health (NIH). He begins his two-year term effective July 1, 2022.
Findings from a new study published in PLOS ONE, led by investigators at Dartmouth’s Geisel School of Medicine and Muhimibili University of Health and Allied Sciences, show high rates of new tuberculosis (TB) infection among adolescents in Tanzania—highlighting the importance of developing TB control measures for this high-risk age group.
The Geisel School of Medicine at Dartmouth remains deeply committed to women’s healthcare and reproductive rights for all, including childbearing decisions, maternal health, and their effect on families through our research and education missions.
On May 20, 2022, the Geisel School of Medicine Alumni Awards Ceremony was held in person for the first time since 2019. The seven honorees were joined by fellow alumni, Geisel faculty and students, family, friends, and colleagues.
Geisel med students learn cooking skills that translate nutrition and lifestyle recommendation into sustainable daily habits.
During this year’s annual community service day, Geisel School of Medicine student volunteer projects benefited Dartmouth Health Children’s Molly’s Place at the CHaD Family Center.
On Friday afternoon, June 10, The Dartmouth Institute for Health Policy and Clinical Practice celebrated the academic accomplishments of 102 of its MPH and MS graduates during its annual Class Day ceremony.
Geisel second-year MD student Armin Tavakkoli has been awarded a 2022 AOA Carolyn L. Kuckein Student Research Fellowship, which will support his research project to evaluate the therapeutic potential of FLASH radiation therapy in treatment of certain types of brain tumors.
Steven Woloshin, MD, MS, a professor of medicine and community and family medicine, and co-director of the Master of Health Care Delivery Science program at The Dartmouth Institute for Health Policy and Clinical Practice, discusses the controversy surrounding the FDA’s approval of Aducanumab—a new drug to treat mild Alzheimer disease.
On Saturday morning, May 28, the Geisel School of Medicine’s 99 graduates joyously gathered with family and friends outdoors on Dartmouth’s Class of 1978 Life Sciences Center lawn to celebrate the close of their academic studies and the beginning of their careers as physicians.